drugset / Trial / NCT00351169

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

NCT00351169

Phase 3 Completed 450 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of quetiapine fumarate sustained release (Seroquel SR) in the treatment of Major Depressive Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Timeline

Start
2006-05
Primary completion
Completion
2007-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule
Subject Quetiapine Small molecule